METTL3 and breast cancer: In bladder and breast cancer, METTL3 mediates PD-L1 mRNA m6A modification and upregulates its expression through IGF2BP3-dependent manner, resulting the exhaustion of T-cells and the suppression of T cell activation and infiltration (24, 26).